MatTek Life Sciences

📍 Ashland, United States🗓 Founded 1985👥 57 employees💰 Last funded Jan 1995
Biotechnology Research🌐 mattek.com
Website LinkedIn
MatTek Life Sciences is at the forefront of tissue engineering and is a world leader in the production of innovative 3D reconstructed human tissue models. Our skin, ocular, and respiratory tissue models are used in regulatory toxicology (OECD, EU guidelines) and address toxicology and efficacy concerns throughout the cosmetics, chemical, pharmaceutical and household product industries. With facilities in the U.S. and Slovakia, MatTek's human cell-derived tissue models are widely used in the United States, Europe and Japan. Our record of scientific and technological innovation remains strong as we continue to develop and validate new in vitro assays, human tissue models and optically advanced cultureware. We invite you to use our products, services and technical solutions, which will afford your company new opportunities in obtaining faster, cost-effective, more reliable and human-relevant results compared to the traditional assays and 2D in vitro systems.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
1985
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in MatTek Life Sciences?
MatTek Life Sciences has 1 investors on record on gritt.io and 1 late-stage investors.
When did MatTek Life Sciences last raise funding?
The most recent investment in MatTek Life Sciences recorded on gritt.io was in January 1995.
When was MatTek Life Sciences founded?
MatTek Life Sciences was founded in 1985.
What industry is MatTek Life Sciences in?
MatTek Life Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MatTek Life Sciences based?
MatTek Life Sciences is headquartered in Ashland, United States.